1. Home
  2. FITB vs RMD Comparison

FITB vs RMD Comparison

Compare FITB & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FITB

Fifth Third Bancorp

HOLD

Current Price

$50.46

Market Cap

31.4B

Sector

Finance

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$253.15

Market Cap

36.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FITB
RMD
Founded
1858
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.4B
36.4B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
FITB
RMD
Price
$50.46
$253.15
Analyst Decision
Buy
Buy
Analyst Count
17
12
Target Price
$51.76
$291.10
AVG Volume (30 Days)
6.6M
880.0K
Earning Date
01-20-2026
01-29-2026
Dividend Yield
3.25%
0.93%
EPS Growth
11.70
29.59
EPS
3.35
9.77
Revenue
$8,125,000,000.00
$5,257,400,000.00
Revenue This Year
$15.96
$9.85
Revenue Next Year
$29.71
$7.34
P/E Ratio
$14.67
$26.36
Revenue Growth
0.77
9.36
52 Week Low
$32.25
$199.92
52 Week High
$50.47
$293.81

Technical Indicators

Market Signals
Indicator
FITB
RMD
Relative Strength Index (RSI) 67.01 53.46
Support Level $47.78 $240.00
Resistance Level $48.86 $261.36
Average True Range (ATR) 1.08 5.40
MACD -0.04 1.27
Stochastic Oscillator 93.80 60.56

Price Performance

Historical Comparison
FITB
RMD

About FITB Fifth Third Bancorp

Fifth Third Bancorp is a diversified financial-services company headquartered in Cincinnati. The company has over $210 billion in assets and operates numerous full-service banking branches and ATMs throughout Ohio, Kentucky, Indiana, Michigan, Illinois, Florida, Tennessee, West Virginia, Georgia, and North Carolina.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: